1
|
Pham LL, Varon E, Bonacorsi S, Boubaya M, Benhaim P, Amor-Chelihi L, Houlier M, Koehl B, Missud F, Brousse V, Gajdos V, Bizot E, Briand C, Malka A, Odièvre MH, Romain AS, Hau I, Pondarré C, See H, Guitton C, Zenkhri F, Holvoet L, Benkerrou M, Da Silveira C, Belaid N, Laurent O, Vassal M, Basmaci R, Aupiais C, Bloch-Queyrat C, Lévy C, Cohen R, Ouldali N, De Pontual L, Carbonnelle E, Gaschignard J. Nasopharyngeal Carriage and Antibiotic Resistance in Children With Sickle Cell Disease: The DREPANOBACT French Multicenter Prospective Study. Pediatr Infect Dis J 2025; 44:387-393. [PMID: 40232881 DOI: 10.1097/inf.0000000000004744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2025]
Abstract
BACKGROUND Children with sickle cell disease (SCD) are susceptible to invasive bacterial infections, particularly those caused by Streptococcus pneumoniae . Data concerning nasopharyngeal carriage remain scarce in this population at high risk of resistant bacteria owing to antibiotic pressure and frequent hospitalizations. METHODS We conducted this prospective trial, DREPANOBACT, in 7 French hospitals to assess the nasopharyngeal carriage rate for S. pneumoniae among children with SCD aged 6 months-15 years between September 2022 and April 2024. The secondary aim was to determine the serotype distribution and proportion of penicillin nonsusceptible S. pneumoniae isolates and the carriage and antibiotic resistance rates for Staphylococcus aureus, Moraxella catarrhalis and Haemophilus influenzae. RESULTS In total, 300 children were enrolled [median age, 8 years (interquartile range: 4-12 years)]. S. pneumoniae carriage accounted for 32 cases (11%), including 21 penicillin nonsusceptible S. pneumoniae strains (66%). The main serotypes were 23A (n = 4), 35B (n = 4), 11A (n = 3) and 15C (n = 3). Overall, 75% of the serotypes were non-13-valent pneumococcal conjugate vaccine (PCV) serotypes, with 19% and 53% covered by PCV20 and PCV21, respectively. The carriage rates for S. aureus, M. catarrhalis and H. influenzae were 31%, 17% and 11%, respectively. Methicillin resistance was observed in 5% of S. aureus strains. Age ≤5 years was significantly associated with S. pneumoniae, M. catarrhalis , and H. influenzae carriage, while age ≥11 years was associated with S. aureus carriage. CONCLUSIONS Surveillance of nasopharyngeal carriage in children with SCD is warranted to monitor changes in predominant serotypes and resistance patterns.
Collapse
Affiliation(s)
- Luu-Ly Pham
- From the Pediatrics Department, Jean Verdier Hospital, AP-HP, Sorbonne Paris-Nord University, Bondy
- IAME EVRest, INSERM UMR1137, Paris
| | - Emmanuelle Varon
- Department of Microbiology, National Reference Center for Pneumococci NRCP, Intercommunal hospital, Créteil
- ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil
| | - Stéphane Bonacorsi
- IAME EVRest, INSERM UMR1137, Paris
- ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil
- Microbiology Department, Robert Debré Hospital, AP-HP, Paris
| | | | | | | | - Marine Houlier
- Pediatrics Department, Louis Mourier Hospital, AP-HP, Colombes
| | - Bérengère Koehl
- Hematology Department, Sickle cell disease Center, Robert Debré Hospital, AP-HP, Paris
| | - Florence Missud
- Hematology Department, Sickle cell disease Center, Robert Debré Hospital, AP-HP, Paris
| | - Valentine Brousse
- Hematology Department, Sickle cell disease Center, Robert Debré Hospital, AP-HP, Paris
| | - Vincent Gajdos
- General Pediatrics Department, Antoine-Béclère Hospital, AP-HP, Paris Saclay University, Clamart
| | - Etienne Bizot
- General Pediatrics Department, Antoine-Béclère Hospital, AP-HP, Paris Saclay University, Clamart
| | - Coralie Briand
- From the Pediatrics Department, Jean Verdier Hospital, AP-HP, Sorbonne Paris-Nord University, Bondy
| | - Alexandra Malka
- From the Pediatrics Department, Jean Verdier Hospital, AP-HP, Sorbonne Paris-Nord University, Bondy
| | | | | | - Isabelle Hau
- Pediatrics Department, Intercommunal Hospital, Créteil
| | - Corinne Pondarré
- Pediatrics Department, Intercommunal Hospital, Créteil
- INSERM U955, IMRB, Paris XII University, Créteil
| | - Hélène See
- Pediatrics Department, Louis Mourier Hospital, AP-HP, Colombes
| | - Corinne Guitton
- Department of Pediatrics, Sickle cell disease Center, Bicêtre Hospital, AP-HP, Kremlin-Bicêtre
| | - Férielle Zenkhri
- Department of Pediatrics, Sickle cell disease Center, Bicêtre Hospital, AP-HP, Kremlin-Bicêtre
| | - Laurent Holvoet
- Hematology Department, Sickle cell disease Center, Robert Debré Hospital, AP-HP, Paris
| | - Malika Benkerrou
- Hematology Department, Sickle cell disease Center, Robert Debré Hospital, AP-HP, Paris
| | - Charlène Da Silveira
- From the Pediatrics Department, Jean Verdier Hospital, AP-HP, Sorbonne Paris-Nord University, Bondy
| | - Nabil Belaid
- Department of Pediatrics, Sickle cell disease Center, Jean Verdier Hospital, AP-HP, Bondy
| | - Odile Laurent
- Pediatrics Department, Louis Mourier Hospital, AP-HP, Colombes
| | | | - Romain Basmaci
- Pediatrics Department, Louis Mourier Hospital, AP-HP, Colombes
| | - Camille Aupiais
- From the Pediatrics Department, Jean Verdier Hospital, AP-HP, Sorbonne Paris-Nord University, Bondy
| | | | - Corinne Lévy
- ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil
| | - Robert Cohen
- ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil
| | - Naïm Ouldali
- IAME EVRest, INSERM UMR1137, Paris
- Pediatrics Department, Robert Debré Hospital, AP-HP, Paris
| | - Loïc De Pontual
- From the Pediatrics Department, Jean Verdier Hospital, AP-HP, Sorbonne Paris-Nord University, Bondy
| | - Etienne Carbonnelle
- IAME EVRest, INSERM UMR1137, Paris
- Microbiology Department, Avicenne Hospital, AP-HP, Bobigny
| | - Jean Gaschignard
- IAME EVRest, INSERM UMR1137, Paris
- Department of Pediatrics, Groupe Hospitalier Nord-Essonne, Paris Saclay Hospital, Orsay, France
| |
Collapse
|
2
|
Mutagonda RF, Bwire G, Sangeda RZ, Kilonzi M, Mlyuka H, Ndunguru J, Jonathan A, Makani J, Minja IK, Ruggajo P, Balandya E, Kamuhabwa AAR. Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania. Infect Drug Resist 2022; 15:4407-4418. [PMID: 35992757 PMCID: PMC9390788 DOI: 10.2147/idr.s367873] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Accepted: 06/03/2022] [Indexed: 01/30/2023] Open
Abstract
Background Bacterial infections contribute significantly to morbidity and mortality in sickle cell disease (SCD) patients, particularly children under five years of age. In Tanzania, prophylaxis against pneumococcal infection among children with SCD advocates the use of both oral penicillin V (PV) and pneumococcal vaccines (PNV). Therefore, this study aimed to investigate nasopharyngeal carriage and antibiogram of Streptococcal pneumoniae (S. pneumoniae) and Staphylococcus aureus (S. aureus) in children with SCD in Tanzania. Methods This cross-sectional study was undertaken at the two Sickle Pan-African Research Consortium (SPARCO) study sites in Dar es salaam, Tanzania. The study was conducted for six months and enrolled children with SCD between the ages of 6 to 59-months. A semi-structured questionnaire was used to collect patient data. Nasopharyngeal swabs were collected from all participants and cultured for Streptococcal pneumoniae and other bacterial isolates. Antimicrobial susceptibility tests of the isolates were done using the disc diffusion method. Results Out of 204 participants, the overall prevalence of bacterial carriage was 53.4%, with S. aureus (23.5%), coagulase-negative Staphylococci (CoNS) (23%) and S. pneumoniae (7.8%) being commonly isolated. In antibiotic susceptibility testing, S. aureus isolates were most resistant to penicillin (81.8%), whereas 81.3% of S. pneumoniae isolates were resistant to co-trimoxazole. The least antimicrobial resistance was observed for chloramphenicol for both S. aureus and S. pneumoniae isolates (6.3% versus 0%). The proportion of multi-drug resistance (MDR) was 66.7% for S. aureus isolates and 25% for S. pneumoniae isolates. Conclusion There are substantially high nasopharyngeal carriage pathogenic bacteria in children with SCD in Dar es Salaam, Tanzania. The presence of MDR strains to the commonly used antibiotics suggests the need to reconsider optimizing antimicrobial prophylaxis in children with SCD and advocacy on pneumococcal vaccines.
Collapse
Affiliation(s)
- Ritah F Mutagonda
- Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania,Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania,Correspondence: Ritah F Mutagonda, Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, P.O BOX 65013, Dar es salaam, Tanzania, Tel +255 713 816481, Email ;
| | - George Bwire
- Department of Pharmaceutical Microbiology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Raphael Zozimus Sangeda
- Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania,Department of Pharmaceutical Microbiology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Manase Kilonzi
- Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Hamu Mlyuka
- Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Joyce Ndunguru
- Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania,Department of Hematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Agnes Jonathan
- Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania,Department of Hematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Julie Makani
- Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania,Department of Hematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Irene Kida Minja
- Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania,Department of Restorative Dentistry, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Paschal Ruggajo
- Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania,Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Emmanuel Balandya
- Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania,Department of Physiology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| | - Appolinary A R Kamuhabwa
- Department of Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania
| |
Collapse
|
3
|
Appiah VA, Pesewu GA, Kotey FCN, Boakye AN, Duodu S, Tette EMA, Nyarko MY, Donkor ES. Staphylococcus aureus Nasal Colonization among Children with Sickle Cell Disease at the Children's Hospital, Accra: Prevalence, Risk Factors, and Antibiotic Resistance. Pathogens 2020; 9:pathogens9050329. [PMID: 32354004 PMCID: PMC7280972 DOI: 10.3390/pathogens9050329] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2020] [Revised: 04/23/2020] [Accepted: 04/23/2020] [Indexed: 01/20/2023] Open
Abstract
The aim of this study was to investigate S. aureus carriage among children with sickle cell disease (SCD), including the prevalence, risk factors, and antibiotic resistance. The study was cross-sectional, and involved 120 children with SCD recruited at the Princess Marie Louise Children’s Hospital (PML) in Accra and 100 apparently healthy children from environs of the hospital. Nasal swab samples were collected from the study participants and cultured for bacteria. Confirmation of S. aureus and methicillin-resistant Staphylococcus aureus (MRSA) isolates were done using the tube coagulase test and mecA polymerase chain reaction, respectively. All the S. aureus isolates were tested against standard antimicrobial agents using the Kirby-Bauer method. A structured questionnaire was used to obtain the socio-demographic and clinical data of the study participants. Binary logistic regression was used to identify determinants of S. aureus and MRSA carriage among the study participants. The nasal carriage prevalence of S. aureus was 33.3% (n = 40) and 10% (n = 10) among the participants of the SCD and control groups, respectively. As regards MRSA nasal carriage prevalence, the respective values were 3.33% (n = 4) and 0.00% (n = 0). SCD was significantly associated with S. aureus colonization (p < 0.0001, OR = 4.045), but not MRSA colonization (p = 0.128). In the SCD group, the significant predictors of S. aureus carriage were increasing age (p = 0.003; OR = 1.275) and living in self-contained apartments (p = 0.033; OR = 3.632), whereas male gender (p = 0.018; OR = 0.344) and the practice of self-medication (p = 0.039; OR = 0.233) were protective of S. aureus carriage. In the control group, a history of hospitalization in the past year was a risk factor for the carriage of S. aureus (p = 0.048; OR = 14.333). Among the participants of the SCD and control groups, respectively, the resistance prevalence recorded by S. aureus against the various antibiotics investigated were penicillin (100% each), cotrimoxazole (27.5% vs. 20%), tetracycline (25% vs. 50%), rifampicin (82.5% vs. 50%), erythromycin (30% vs. 20%), clindamycin (32.5% vs. 50%), gentamicin (7.5% vs. 20%), cefoxitin (27.5% vs. 20%), linezolid (30% vs. 40%), and fusidic acid (95% vs. 80%). The proportion of S. aureus isolates that were multidrug resistant (MDR) was 92.5% (37/40) in the SCD group and 100% (10/10) in the control group.
Collapse
Affiliation(s)
- Vera A. Appiah
- Department of Medical Laboratory Science, School of Biomedical and Allied Health Sciences, University of Ghana, Legon P. O. Box LG 54, Accra, Ghana
| | - George A. Pesewu
- Department of Medical Laboratory Science, School of Biomedical and Allied Health Sciences, University of Ghana, Legon P. O. Box LG 54, Accra, Ghana
| | - Fleischer C. N. Kotey
- FleRhoLife Research Consult, Teshie P. O. Box TS 853, Accra, Ghana
- Department of Medical Microbiology, University of Ghana Medical School, Accra P. O. Box 4236, Ghana
| | - Alahaman Nana Boakye
- Department of Medical Laboratory Science, School of Biomedical and Allied Health Sciences, University of Ghana, Legon P. O. Box LG 54, Accra, Ghana
- FleRhoLife Research Consult, Teshie P. O. Box TS 853, Accra, Ghana
| | - Samuel Duodu
- West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Legon P. O. Box LG 54, Accra, Ghana
- Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Legon P. O. Box LG 54, Accra, Ghana
| | - Edem M. A. Tette
- Department of Community Health, University of Ghana Medical School, Accra P. O. Box 4236, Ghana
| | - Mame Y. Nyarko
- Princess Marie Louise Children’s Hospital, Accra P. O. Box GP 122, Ghana
| | - Eric S. Donkor
- Department of Medical Microbiology, University of Ghana Medical School, Accra P. O. Box 4236, Ghana
- Correspondence: or ; Tel.: +233-553-527-140
| |
Collapse
|
4
|
Antimicrobial Resistance Profiles for Different Isolates in Aden, Yemen: A Cross-Sectional Study in a Resource-Poor Setting. BIOMED RESEARCH INTERNATIONAL 2020; 2020:1810290. [PMID: 32382529 PMCID: PMC7195635 DOI: 10.1155/2020/1810290] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Accepted: 04/02/2020] [Indexed: 11/17/2022]
Abstract
Background There is a rapid deterioration in the effectiveness of antibiotics due to the global prevalence of bacterial antimicrobial resistance (AMR). AMR can cause an increase in mortality and morbidity due to treatment failures and a lack of effective therapy. Objective The purpose of this study was to evaluate the AMR pattern of different bacterial isolates at hospitals and laboratories. Materials and Methods A cross-sectional study from March 2019 to June 2019 was conducted at different governmental and private hospitals and laboratories in Aden, Yemen. Age, sex, specimen type, bacterial isolates, and antibiotic susceptibility pattern were collected using a data extraction sheet. Descriptive statistics were used for data analysis. Result Data were recorded for 412 patients from whom 20 clinical specimens were collected and analyzed. The most common bacteria isolated were Staphylococcus spp. (n = 172, 41.74%), E. coli (n = 164, 39.80%), Pseudomonas spp. (n = 37, 8.98%), and Klebsiella pneumoniae (n = 18, 4.36%); other bacteria were less common. The overall bacterial resistance was highest against the combination of sulfamethoxazole with trimethoprim (73.12%), followed by amoxicillin and clavulanate (65.19%). The cephalosporin antibiotics also showed high resistance rates. The study also showed moderate bacterial resistance to gentamycin (32.65%), azithromycin (29.92%), cefoxitin (62.65%), and ciprofloxacin (25.60%). Ertapenem (16.67%) and levofloxacin (15.56%) had the lowest resistance rates. Conclusion There was a high percentage of bacteria resistant to several antibiotics. Antibiotic susceptibility testing is a prerequisite guide for the selection of appropriate antibiotic therapy for bacterial infections.
Collapse
|
5
|
Dayie NTKD, Tetteh-Ocloo G, Labi AK, Olayemi E, Slotved HC, Lartey M, S. Donkor E. Pneumococcal carriage among sickle cell disease patients in Accra, Ghana: Risk factors, serotypes and antibiotic resistance. PLoS One 2018; 13:e0206728. [PMID: 30408061 PMCID: PMC6224078 DOI: 10.1371/journal.pone.0206728] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2018] [Accepted: 10/18/2018] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND Pneumococcal carriage is the precursor for development of pneumococcal disease, and is also responsible for transmission of the organism from person-to-person. Individuals with Sickle Cell Disease (SCD) are more likely to develop invasive disease with S. pneumoniae compared to their healthy counterparts and the presentation of disease in the former is usually abrupt and severe. In Africa, little is known about the pneumococcus in relation to people with SCD Sickle Cell Disease (SCD). The aim of the study was to investigate the epidemiology of pneumococcal carriage among SCD patients including the carriage prevalence, risk factors, serotypes and antibiotic resistance. METHOD This was a cross sectional study involving 402 SCD patients recruited from Korle Bu Teaching Hospital and Princess Marie Louis Hospital in Accra from October 2016 to March 2017. The study subjects included 202 children of the age groups: ≤5 years (94), >5-9 years (75), ≥10-13 years (33) and 200 adults of the age groups: 14-20 years (46), 21-40 years (112), 41-60 years (25), ≤ 61 years (17). Nasopharyngeal (NP) swabs were collected from the study participants as well as epidemiological data on demographic, household and clinical features. The NP specimens were cultured for S. pneumoniae and the isolates were serotyped by latex agglutination. Antimicrobial susceptibility tests of the isolates were done by the disc diffusion test and E-test. RESULTS Prevalence of S. pneumoniae carriage among children and adult SCD patients enrolled in the study were 79/202 (39.1%; 95% CI: 32.3 to 46.2) and 20/200 (10.0%; 95% CI: 6.2 to 15.0) respectively. Risk factors associated with pneumococcal carriage were age (OR = 1.137; 95% CI: 1.036-1.248; p = 0.007) and runny nose (OR = 5.371; 95% CI: 1.760-16.390; p = 0.003). Overall, twenty-six pneumococcal serotypes were isolated from the study participants and the predominant serotype was 6B (10.6%), followed by 23B (8.2%). Among the children, serotype coverage of the 13-valent Pneumococcal Conjugate Vaccine, which is currently used in Ghana was 32.4%. Prevalence of penicillin resistance among the pneumococcal isolates was 37.4% (37/99) and all the penicillin-resistant isolates exhibited intermediate penicillin resistance with the exception of one isolate that showed full resistance and was susceptible to ceftriaxone. Prevalence of resistance to the other antibiotics ranged from 2.5% (levofloxacin) to 85% (cotrimoxazole). Multidrug resistance occurred among 34.3% (34/99) of the pneumococcal isolates. CONCLUSION Pneumococcal carriage was four-fold higher in SCD children than adults and was characterized by predominance of non-vaccine serotypes and considerable level of multidrug resistance, though penicillin, cefotaxime and levofloxacin resistance appeared to be very low.
Collapse
Affiliation(s)
- Nicholas T. K. D. Dayie
- Dept. of Medical Microbiology, School of Biomedical and Allied Health Sciences University of Ghana, Accra, Ghana
| | - Georgina Tetteh-Ocloo
- Dept. of Medical Microbiology, School of Biomedical and Allied Health Sciences University of Ghana, Accra, Ghana
| | | | - Edeghonghon Olayemi
- Dept. of Haemataology, School of Biomedical and Allied Health Sciences, University of Ghana, Accra, Ghana
| | - Hans-Christian Slotved
- Statens Serum Institut, Dept of Microbiological Surveillance and Research, Copenhagen, Denmark
| | - Margaret Lartey
- Dept. of Medicine, School of Medicine and Dentistry, University of Ghana, Accra, Ghana
| | - Eric S. Donkor
- Dept. of Medical Microbiology, School of Biomedical and Allied Health Sciences University of Ghana, Accra, Ghana
| |
Collapse
|
6
|
Mourembou G, Fenollar F, Socolovschi C, Lemamy GJ, Nzoughe H, Kouna LC, Toure-Ndouo F, Million M, Mbiguino AN, Lekana-Douki JB, Raoult D. Molecular Detection of Fastidious and Common Bacteria as Well as Plasmodium spp. in Febrile and Afebrile Children in Franceville, Gabon. Am J Trop Med Hyg 2015; 92:926-32. [PMID: 25802432 DOI: 10.4269/ajtmh.14-0699] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2014] [Accepted: 02/07/2015] [Indexed: 01/19/2023] Open
Abstract
Malaria was considered as the main cause of fever in Africa. However, with the roll back malaria initiative, the causes of fever in Africa may change. This study aimed to evaluate the prevalence of bacteria and Plasmodium spp. in febrile and afebrile (controls) children from Franceville, Gabon. About 793 blood samples from febrile children and 100 from controls were analyzed using polymerase chain reaction (PCR) coupled with sequencing. Plasmodium spp. was the microorganism most detected in febrile (74.5%, 591/793) and controls (13%, 13/100), P < 0.0001. Its coinfection with bacteria was found only in febrile children (P = 0.0001). Staphylococcus aureus was the most prevalent bacterium in febrile children (2.8%, 22/793) and controls (3%, 3/100). Eight cases of Salmonella spp. (including two Salmonella enterica serovar Paratyphi) and two of Streptococcus pneumoniae were found only among febrile children. Borrelia spp. was found in 2 controls while Rickettsia felis was detected in 10 children (in 8 febriles and 2 afebriles). No DNA of other targeted microorganisms was detected. Plasmodium spp. remains prevalent while Salmonella spp., Staphylococcus aureus, and Streptococcus pneumoniae were common bacteria in Gabon. Two fastidious bacteria, Rickettsia felis and Borrelia spp., were found. Inclusion of controls should improve the understanding of the causes of fever in sub-Saharan Africa.
Collapse
Affiliation(s)
- Gaël Mourembou
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Florence Fenollar
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Cristina Socolovschi
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Guy Joseph Lemamy
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Hermann Nzoughe
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Lady Charlene Kouna
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Fousseyni Toure-Ndouo
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Matthieu Million
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Angelique Ndjoyi Mbiguino
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Jean Bernard Lekana-Douki
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| | - Didier Raoult
- URMITE, Aix Marseille Université, Marseille, France; Unité de Parasitologie Médicale (UPARAM) CIRMF, Franceville, Gabon; Ecole Doctorale Régionale d'Afrique Centrale, Franceville, Gabon; Département de Biologie Cellulaire et Génétique, Université des Science de la Santé, Libreville, Gabon; Département de Parasitologie Mycologie et de Médecine Tropicale, Université des Science de la Santé, Libreville, Gabon; Département de Microbiologie, Laboratoire National de Référence IST/sida, Faculté de Médecine, Université des Sciences de la Santé, Libreville, Gabon
| |
Collapse
|
7
|
Kraef C, Alabi AS, Peters G, Becker K, Kremsner PG, Rossatanga EG, Mellmann A, Grobusch MP, Zanger P, Schaumburg F. Co-detection of Panton-Valentine leukocidin encoding genes and cotrimoxazole resistance in Staphylococcus aureus in Gabon: implications for HIV-patients' care. Front Microbiol 2015; 6:60. [PMID: 25699036 PMCID: PMC4318419 DOI: 10.3389/fmicb.2015.00060] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2014] [Accepted: 01/17/2015] [Indexed: 12/28/2022] Open
Abstract
Patients infected with the human immunodeficiency virus (HIV) are frequently exposed to antimicrobial agents. This might have an impact on the resistance profile, genetic background and virulence factors of colonizing Staphylococcus aureus. Sub-Saharan Africa is considered to be endemic for Panton-Valentine leukocidin (PVL) positive S. aureus which can be associated with skin and soft tissue infections (SSTI). We compared S. aureus from nasal and pharyngeal swabs from HIV patients (n = 141) and healthy controls (n = 206) in Gabon in 2013, and analyzed determinants of colonization with PVL positive isolates in a cross-sectional study. S. aureus isolates were screened for the presence of selected virulence factors (incl. PVL) and were subjected to antimicrobial susceptibility testing and genotyping. In HIV patients, S. aureus was more frequently detected (36.9 vs. 31.6%) and the isolates were more frequently PVL positive than in healthy controls (42.1 vs. 23.2%). The presence of PVL was associated with cotrimoxazole resistance (OR = 25.1, p < 0.001) and the use of cotrimoxazole was a risk factor for colonization with PVL positive isolates (OR = 2.5, p = 0.06). PVL positive isolates were associated with the multilocus sequence types ST15 (OR = 5.6, p < 0.001) and ST152 (OR = 62.1, p < 0.001). Participants colonized with PVL positive isolates reported more frequently SSTI in the past compared to carriers of PVL negative isolates (OR = 2.7, p = 0.01). In conclusion, the novelty of our study is that cotrimoxazole might increase the risk of SSTI in regions where cotrimoxazole resistance is high and associated with PVL. This finding needs to be confirmed in prospective studies.
Collapse
Affiliation(s)
- Christian Kraef
- Institute of Medical Microbiology, University Hospital Münster Münster, Germany ; Centre de Recherches Médicales de Lambaréné, Albert Schweitzer Hospital Lambaréné, Gabon
| | - Abraham S Alabi
- Centre de Recherches Médicales de Lambaréné, Albert Schweitzer Hospital Lambaréné, Gabon ; Institut für Tropenmedizin, Eberhard Karls Universität, Deutsches Zentrum für Infektionsforschung Tübingen, Germany
| | - Georg Peters
- Institute of Medical Microbiology, University Hospital Münster Münster, Germany
| | - Karsten Becker
- Institute of Medical Microbiology, University Hospital Münster Münster, Germany
| | - Peter G Kremsner
- Centre de Recherches Médicales de Lambaréné, Albert Schweitzer Hospital Lambaréné, Gabon ; Institut für Tropenmedizin, Eberhard Karls Universität, Deutsches Zentrum für Infektionsforschung Tübingen, Germany
| | | | | | - Martin P Grobusch
- Centre de Recherches Médicales de Lambaréné, Albert Schweitzer Hospital Lambaréné, Gabon ; Institut für Tropenmedizin, Eberhard Karls Universität, Deutsches Zentrum für Infektionsforschung Tübingen, Germany ; Division of Internal Medicine, Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Academic Medical Center, University of Amsterdam Amsterdam, Netherlands
| | - Philipp Zanger
- Institut für Tropenmedizin, Eberhard Karls Universität, Deutsches Zentrum für Infektionsforschung Tübingen, Germany ; Institute of Public Health, University Hospital Heidelberg Heidelberg, Germany
| | - Frieder Schaumburg
- Institute of Medical Microbiology, University Hospital Münster Münster, Germany ; Centre de Recherches Médicales de Lambaréné, Albert Schweitzer Hospital Lambaréné, Gabon
| |
Collapse
|
8
|
Oral microbial colonization in children with sickle cell anaemia under long-term prophylaxis with penicillin. Arch Oral Biol 2014; 59:1042-7. [DOI: 10.1016/j.archoralbio.2014.05.014] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2013] [Revised: 02/12/2014] [Accepted: 05/06/2014] [Indexed: 11/18/2022]
|
9
|
Schaumburg F, Alabi A, Peters G, Becker K. New epidemiology of Staphylococcus aureus infection in Africa. Clin Microbiol Infect 2014; 20:589-96. [DOI: 10.1111/1469-0691.12690] [Citation(s) in RCA: 100] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
10
|
Alabi AS, Frielinghaus L, Kaba H, Kösters K, Huson MAM, Kahl BC, Peters G, Grobusch MP, Issifou S, Kremsner PG, Schaumburg F. Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa. BMC Infect Dis 2013; 13:455. [PMID: 24083375 PMCID: PMC3849904 DOI: 10.1186/1471-2334-13-455] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2013] [Accepted: 09/30/2013] [Indexed: 11/10/2022] Open
Abstract
Background Physicians depend on reliable information on the local epidemiology of infection and antibiotic resistance rates to guide empiric treatment in critically ill patients. As these data are scarce for Central Africa, we performed a retrospective analysis of microbiological findings from a secondary care hospital in Gabon. Methods Microbiological reports from 2009 to 2012 were used to assess the non-susceptibility rates of the three most common isolates from six major types of infections (bloodstream, ear-eye-nose-throat, surgical site, skin and soft tissue, urinary tract and wound infection). Results A high diversity of pathogens was found, but Staphylococcus aureus was predominant in the majority of infections. Overall, the three most prevalent pathogens in children were S. aureus (33.7%), Streptococcus pyogenes (8.1%) and Escherichia coli (4.5%) and in adults S. aureus (23.5%), E. coli (15.1%) and Klebsiella pneumoniae (7.4%). In total, 5.8% (n = 19) of all S. aureus isolates were methicillin resistant. The proportion of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae was 15.4% (n = 78), 49.4% of all K. pneumoniae were ESBL-producer (n = 42). Conclusion The high diversity of potential pathogens and high resistance rates in Gram-negative bacteria challenge a rational empiric use of antibiotics. Countrywide continuous sentinel surveillance is therefore urgently needed.
Collapse
Affiliation(s)
- Abraham S Alabi
- Centre de Recherche Médicale de Lambaréné (CERMEL), Lambaréné, Gabon.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Donkor ES, Foster-Nyarko E, Enweronu-Laryea CC. Relationship between antibiotic resistance and sickle cell anemia: preliminary evidence from a pediatric carriage study in Ghana. Infect Drug Resist 2013; 6:71-7. [PMID: 23930075 PMCID: PMC3733876 DOI: 10.2147/idr.s40062] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND Antibiotics are frequently used among people with sickle cell anemia (homozygous SS or HbSS disease), especially for prophylaxis. However, the relationship between antibiotic resistance and people with HbSS disease has not been adequately studied, especially in the developing world. The objectives of the study were (1) to compare antibiotic resistance patterns of nasal Staphylococcus aureus between children with HbSS disease and children without HbSS disease (healthy children) and (2) to evaluate nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae among children with HbSS disease. METHODS This was a prospective cross-sectional study, and the subjects were children under 12 years old. Nasal swabs were collected from 50 children with HbSS disease and 50 children without HbSS disease. Nasopharyngeal swabs were collected from another group of 92 children with HbSS disease. The nasal and nasopharyngeal swabs were cultured for S. aureus and S. pneumoniae, respectively. Susceptibility testing was carried out on the S. aureus and S. pneumoniae isolates for various antibiotics, including penicillin, ampicillin, cefuroxime, erythromycin, cloxacillin, and cotrimoxazole. RESULTS The carriage rates of S. aureus among pediatric subjects with HbSS disease and those without HbSS disease were 48% and 50%, respectively (P > 0.05). S. pneumoniae carriage among the pediatric subjects with HbSS disease was 10%. Antibiotic resistance patterns of S. aureus carried by children with HbSS disease and children without HbSS disease were similar, and the S. aureus resistance rates were >40% for the various antibiotics, with the exception of erythromycin and cloxacillin. Low levels of S. pneumoniae resistance (0%-11%) were observed for the various antibiotics tested except cotrimoxazole, which showed an extremely high-percentage resistance (100%). CONCLUSION Sickling status is not a risk factor for carriage of S. aureus. In this cohort of Ghanaian children with HbSS disease, S. aureus is higher in carriage and more antibiotic-resistant, compared to S. pneumoniae.
Collapse
Affiliation(s)
- Eric S Donkor
- Department of Microbiology, University of Ghana Medical School, Accra, Ghana
| | - Ebenezer Foster-Nyarko
- Department of Medical Laboratory Science, School of Allied Health Sciences, University of Ghana, Accra, Ghana
| | | |
Collapse
|
12
|
Bacterial respiratory pathogens in children with inherited immune and airway disorders: nasopharyngeal carriage and disease risk. Pediatr Infect Dis J 2013; 32:399-404. [PMID: 23552676 DOI: 10.1097/inf.0b013e31827db77a] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Children with primary immunodeficiencies, sickle cell disease and cystic fibrosis are at risk to develop invasive bacterial infections caused by respiratory tract pathogens, in particular Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus. This review article evaluates the role of nasopharyngeal colonization by these pathogens in the high prevalence of respiratory and invasive infections in children with inherited disorders affecting the immune system or the respiratory tract. We conclude that respiratory and invasive diseases that occur in children with primary immunodeficiencies or sickle cell disease are probably a result of increased nasopharyngeal colonization rates compared with healthy children. However, when the inherited disorder is characterized by local airway abnormalities such as in cystic fibrosis, enhanced nasopharyngeal colonization does not seem to play a major role in invasive disease risk. As the evidence for the role of nasopharyngeal colonization in disease risk in these specific patient groups partly comes from experimental studies and animal models, longitudinal studies in children are needed. Detailed understanding of the effect of colonization on the development of respiratory and invasive infections in children with primary immunodeficiencies, sickle cell disease or cystic fibrosis provides a justification for the selective introduction of vaccination and prophylactic antibiotic treatment. Recommendations for the use of (preventive) therapeutic strategies in these patient groups taking into account disease-specific immunologic mechanisms underlying colonization and disease are described.
Collapse
|